Advertisement

Topics

[Comment] CD8 T cells and mTOR: new concepts and targets for systemic lupus erythematous

21:18 EDT 15 Mar 2018 | The Lancet

Management of systemic lupus erythematosus and its variable clinical manifestations remain considerable challenges for clinicians and patients. Advances in characterising mechanisms of immune system regulation have been applied to studies of systemic lupus erythematosus, implicating type I interferon and highlighting the contributions of T and B lymphocytes to autoantibody production and tissue damage.1 Despite such progress, the pace of development of more effective therapies for patients has been slow.

Original Article: [Comment] CD8 T cells and mTOR: new concepts and targets for systemic lupus erythematous

NEXT ARTICLE

More From BioPortfolio on "[Comment] CD8 T cells and mTOR: new concepts and targets for systemic lupus erythematous"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Lupus
Lupus is a complex and poorly understood condition that affects many parts of the body and causes symptoms ranging from mild to life-threatening. There are several types of lupus. The main types are: discoid lupus erythematosus drug-induced lu...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...